首页 | 本学科首页   官方微博 | 高级检索  
检索        

阻塞性睡眠呼吸暂停低通气综合征合并2型糖尿病患者血清Nesfatin-1的变化及意义
引用本文:郑国君,巫小燕,施正贤,王艳,李锐.阻塞性睡眠呼吸暂停低通气综合征合并2型糖尿病患者血清Nesfatin-1的变化及意义[J].中国耳鼻咽喉头颈外科,2017,24(5):260.
作者姓名:郑国君  巫小燕  施正贤  王艳  李锐
作者单位:浙江中医药大学附属温州中西医结合医院耳鼻咽喉科,浙江 温州,325000
摘    要:目的 探讨阻塞性睡眠呼吸暂停低通气综合征(OSAHS)合并2型糖尿病(type 2 diabetes mellitus,T2DM)患者血清Nesfatin-1的变化及意义。方法 收集2014年12月~2015年4月就诊于我院耳鼻咽喉科、呼吸科、内分泌科、体检中心及睡眠监测室的25例OSAHS患者(OSAHS组)、OSAHS合并T2DM患者(OSAHS合并T2DM组)和25例对照组为研究对象。所有受试者均进行整夜7h的多道睡眠图监测,并测量研究对象的身高、腰围、颈围、体质量指数(BMI),检测各组血清Nesfatin-1水平和空腹血糖(Fasting blood glucose,FBG)水平。结果 各组性别、年龄、身高、腰围、颈围无统计学差异。与对照组比较,OSAHS组和OSAHS合并T2DM组体重及BMI差异具有统计学意义(P <0.05);OSAHS合并T2DM组与OSAHS组FPG高于对照组,且OSAHS合并T2DM组高于OSAHS组,且均有统计学差异(P <0.05);OSAHS合并T2DM组AHI高于OSAHS组,且均有统计学差异(P <0.05);OSAHS合并T2DM组和OSAHS组血清Nesfatin-1含量高于对照组,且有统计学差异(P <0.05);FPG、AHI与Nesfatin-1呈正相关。结论 OSAHS合并T2DM患者血清Nesfatin-1存在较高的水平。

关 键 词:睡眠呼吸暂停  阻塞性  糖尿病  2型  核组蛋白2  摄食抑制因子  

Changes and clinical significance of serum Nesfatin-1 in patients with obstructive sleep apnea hypopnea syndrome and type 2 diabetes mellitus
ZHENG Guojun,WU Xiaoyan,SHI Zhengxian,WANG Yan,LI Rui.Changes and clinical significance of serum Nesfatin-1 in patients with obstructive sleep apnea hypopnea syndrome and type 2 diabetes mellitus[J].Chinese Archives of Otolaryngology-Head and Neck Surgery,2017,24(5):260.
Authors:ZHENG Guojun  WU Xiaoyan  SHI Zhengxian  WANG Yan  LI Rui
Abstract:OBJECTIVE To investigate the changes and clinical significance of serum Nesfatin-1 in patients with obstructive sleep apnea hypopnea syndrome(OSAHS) and type 2 diabetes mellitus (T2DM).METHODS 25 OSAHS cases who visited the department of otolaryngology, pneumology department, endocrinology department, physical examination center and sleep monitoring room from December 2014 to April 2015 were assigned as OSAHS group, and 25 patients with OSAHS and T2DM as OSAHS combination T2DM group, and 25 other patients as control group. All patient were took polysomnography, and the height, waist, neck circumference and BMI with all subjects were recorded. The serum Nesfatin-1 and fast blood glucose levels of all patients were measured.RESULTS The gender, age, height, waist and neck circumference had no statistical difference among all groups. The height and BMI in OSAHS group and OSAHS combination T2DM group were statistically significant difference compared with the control group (P<0.05); the FBG in OSAHS combination T2DM group and OSAHS group were significantly higher than that of the control group, and the FBG in OSAHS combination T2DM group were significantly higher than that of the OSAHS group, with statistically significant(P<0.05); The AHI in OSAHS combination T2DM group were significantly higher than that of the OSAHS group, with statistically significant(P<0.05); the serum Nesfatin-1 in OSAHS combination T2DM group and OSAHS group were significantly higher than that of the control group, with statistically significant(P<0.05); FBG, AHI and Nesfatin-1 were positively correlated with each other.CONCLUSION The serum Nesfatin-1 in patients with OSAHS combination T2DM are in a high level.
Keywords:Sleep Apnea  Obstructive  Diabetes Mellitus  Type 2  NUCB2  Nesfatin-1
本文献已被 万方数据 等数据库收录!
点击此处可从《中国耳鼻咽喉头颈外科》浏览原始摘要信息
点击此处可从《中国耳鼻咽喉头颈外科》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号